Thyrocare Technologies Ltd has signed a Business Transfer Agreement to acquire the diagnostic and pathological services business of Vimta Labs, which recorded revenues of INR 30 Crores in FY 2024 and INR 7 Crores in Q1 FY 2025, aiming to strengthen its presence in Southern India.